Kim Forest Enterprise Co., Ltd. (TPE:6645)
Taiwan · Delayed Price · Currency is TWD 13.50
+1.20 (9.76%)
Oct 8, 2026, 1:24 PM CST
Kim Forest Enterprise Market Cap
Kim Forest Enterprise has a market cap or net worth of 815.18 million as of October 9, 2026. It is the 35,341st most valuable company in the world and the 2,138th biggest in Taiwan. Its market cap has decreased by 41.41% in one year.
Market Cap
815.18M
Enterprise Value
1.21B
Revenue
599.63M
Global Rank
Country Rank
#2,138 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 18, 2017, Kim Forest Enterprise's market cap has increased from 545.05M to 815.18M, an increase of 49.56%. That is a compound annual growth rate of 4.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 815.18M | -24.03% |
| Dec 31, 2025 | 1.07B | -16.65% |
| Dec 31, 2024 | 1.29B | -24.16% |
| Dec 29, 2023 | 1.70B | 21.03% |
| Dec 30, 2022 | 1.40B | 32.47% |
| Dec 30, 2021 | 1.06B | -29.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.95B |
| DIVA Laboratories | 1.81B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.06B |
| Sofiva Genomics | 720.14M |
| TFBS Bioscience | 662.10M |
| Welgene Biotech | 400.83M |
| Pharmigene | 321.64M |